药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Proparacaine
(R)-warfarin
The risk or severity of bleeding can be increased when Clindamycin is combined with (R)-warfarin.
Proparacaine
Acenocoumarol
The risk or severity of bleeding can be increased when Clindamycin is combined with Acenocoumarol.
Proparacaine
Diphenadione
The risk or severity of bleeding can be increased when Clindamycin is combined with Diphenadione.
Proparacaine
Clorindione
The risk or severity of bleeding can be increased when Clindamycin is combined with Clorindione.
Proparacaine
Fluindione
The risk or severity of bleeding can be increased when Clindamycin is combined with Fluindione.
Proparacaine
Ethyl biscoumacetate
The risk or severity of bleeding can be increased when Clindamycin is combined with Ethyl biscoumacetate.
Proparacaine
4-hydroxycoumarin
The risk or severity of bleeding can be increased when Clindamycin is combined with 4-hydroxycoumarin.
Proparacaine
Phenprocoumon
The risk or severity of bleeding can be increased when Clindamycin is combined with Phenprocoumon.
Proparacaine
Tioclomarol
The risk or severity of bleeding can be increased when Clindamycin is combined with Tioclomarol.
Proparacaine
Coumarin
The risk or severity of bleeding can be increased when Clindamycin is combined with Coumarin.
Proparacaine
Metreleptin
The metabolism of Clindamycin can be increased when combined with Metreleptin.
Proparacaine
Cyclopentamine
The risk or severity of adverse effects can be increased when Clindamycin is combined with Cyclopentamine.
Proparacaine
Hexamethonium
The risk or severity of adverse effects can be increased when Clindamycin is combined with Hexamethonium.
Proparacaine
Trimethaphan
The risk or severity of adverse effects can be increased when Clindamycin is combined with Trimethaphan.
Proparacaine
Pentolinium
The risk or severity of adverse effects can be increased when Clindamycin is combined with Pentolinium.
Proparacaine
Magnesium stearate
The risk or severity of neuromuscular blockade can be increased when Clindamycin is combined with Magnesium stearate.
Proparacaine
Dantrolene
The risk or severity of neuromuscular blockade can be increased when Clindamycin is combined with Dantrolene.
Proparacaine
Magnesium acetate
The risk or severity of neuromuscular blockade can be increased when Clindamycin is combined with Magnesium acetate.
Proparacaine
Magnesium phosphate
The risk or severity of neuromuscular blockade can be increased when Clindamycin is combined with Magnesium phosphate.
Proparacaine
Magnesium orotate
The risk or severity of neuromuscular blockade can be increased when Clindamycin is combined with Magnesium orotate.